-
New target immunotoxin! Vicinium initiated rolling submission for the treatment of high-risk BCG unresponsive non muscle invasive bladder cancer (NMIBC
Time of Update: 2019-12-29
December 29, 2019 / Biogen / -- sesen bio is a biopharmaceutical company in the late clinical stage, focusing on the development of targeted fusion protein therapy for cancer Recently, the company ann
-
More than 8000 hospitals have registered on the national drug use monitoring platform
Time of Update: 2019-12-11
▍ 8840 hospitals and statistical information center of the national health and Health Commission for monitoring drug use today announced that the national drug use monitoring platform has been put int
-
122 key monitoring drug prices are exposed, and it is imperative to keep the national drug prices consistent
Time of Update: 2019-09-25
On September 24, Qinghai Province released the notice on publishing the results of filling in the national lowest price enterprises of some drugs, which publicized the national lowest price enterprise
-
Among the infectious diseases in June, 19, hand, foot and mouth disease, cold and hepatitis took the first place
Time of Update: 2019-08-05
On August 2, the National Bureau of disease control and prevention publicized the national epidemic situation of legal infectious diseases in June 2019: a total of 964457 cases of legal infectious dis
-
Does the package of Chinese herbal pieces have a shelf life? Why
Time of Update: 2019-01-21
[market analysis of chinapharma.com] recently, in the interactive exchange column of Anhui food and drug administration, someone asked, "is there a shelf life for the packaging of Chinese herbal piece
-
[exclusive] through the application of diabetes drugs in 2018, new aspartic insulin drugs and DPP-4 inhibitors will be on the market for the first time, focusing on Ganli, Kelun and Tonghua Dongbao
Time of Update: 2018-12-26
Towards the end of 2018, how about the application of diabetes drugs this year? Which new drugs and first imitations will meet us soon? According to the registration and acceptance database of smart d
-
Shanghai Nanhai Pharmaceutical Co., Ltd., a controlling shareholder of 2 billion capital increase
Time of Update: 2018-11-19
On November 16, Hainan Haiyao announced that Xinxing International Pharmaceutical Co., Ltd plans to gain control over Hainan Haiyao by means of cash capital increase in Nanfang Tongzheng, with the cap
-
[perspective] domestic heavyweight new drugs launched in May
Time of Update: 2018-06-08
According to the drug intelligence data, in May, the new drugs were approved with 7 acceptance numbers, involving 5 varieties of drugs Here is a brief look at some of the heavier drugs On May 17, the
-
[exclusive] 2017 local medical insurance supplement summary analysis: many provinces and cities have exceeded the scope of national regulations, and ethnic medicine has broad prospects
Time of Update: 2017-12-26
Since the release of the 2017 national new version of the medical insurance catalogue, the local medical insurance supplement catalogue has also come out People from all walks of life in politics and
-
20 provinces announce the adjustment plan of medical insurance catalogue
Time of Update: 2017-08-29
Source: according to the preliminary statistics of the reporter of the economic reference newspaper 2017-08-29, there are 20 provinces, districts and cities in China that have published the new versio
-
The price of core varieties has increased year by year. How to play next
Time of Update: 2017-07-05
[chinapharma.com news] under the general trend of multiple increases in the prices of precious traditional Chinese medicine, the new round of price increases on May 27 did not seem to attract much att
-
Latest progress of self inspection: 5 products have been approved in the on-site inspection catalog
Time of Update: 2016-10-25
Source: medical economics Daily, October 22, 2016, the on-site verification plan for clinical trial data of drugs No 7 was released In less than seven months, from March 30, 2016, No 1 to October 22,
-
Special inspection on the use of Chinese herbal extracts by drug manufacturers in Deyang City
Time of Update: 2016-05-05
Recently, in accordance with the announcement of the State Administration of food and Drug Administration of Deyang on the implementation of the relevant provisions on the supervision and administrati
-
The 1.1 class of anti Alzheimer's candidate drug GIBH130 has been approved by clinical trial
Time of Update: 2016-04-01
Comparison of brain hippocampal slices of disease model mice: oral administration of gibh-130 can protect neurons According to the Chinese Academy of Sciences, gibh-130 and its tablets, a new anti Alz
-
[report] the rise of domestic drugs for liver diseases
Time of Update: 2016-03-25
The drugs for liver diseases mainly include the drugs for liver treatment in digestive system and metabolism and the drugs for anti hepatitis virus in systemic anti infection Poor drug accessibility i
